Immunotherapy Today

Immunotherapy News From Around The World

Immunotherapy could stop prostate cancer spreading, trial shows

Posted by btwatson on June 3, 2018 1:09 am
Tags:
Categories: Uncategorized

Source: Immunotherapy could stop prostate cancer spreading, trial shows

[unable to retrieve full-text content]

  1. Immunotherapy could stop prostate cancer spreading, trial shows  The Guardian
  2. Immunotherapy prostate cancer drug gives ‘amazing results’  Sky News
  3. Men with advanced prostate cancer could benefit from ‘amazing’ immunotherapy trial  ITV News
  4. Full coverage

Published at Sat, 02 Jun 2018 17:51:00 +0000

< Immunotherapy Today home

Immunotherapy News

  • Disease Factors Can Support Intensification or Deescalation in HSPC - Targeted Oncology
    November 17, 2025
  • Decoding Gut Microbiome’s Role in Immunotherapy - BIOENGINEER.ORG
    November 17, 2025
  • Early Detection, Targeted Therapies, and Immunotherapy Advances in Pancreatic Cancer - Dana-Farber Cancer Institute - Oncodaily
    November 17, 2025
  • Unraveling gut microbiome interferences in cancer immunotherapy: a meta-analysis of diverse drug effects - BMC Cancer
    November 17, 2025
  • Cancer Survival Benefits for Patients Receiving mRNA-based COVID-19 Vaccines - respiratory-therapy.com
    November 17, 2025
  • Candel Therapeutics to Host Virtual R&D Event on December 5, 2025 - Yahoo Finance Singapore
    November 17, 2025
  • COSMIC-313 Correlative Analysis Links Specific T-Cell Subset to Improved PFS with Immunotherapy - Berkay Simsek - UroToday
    November 17, 2025
  • Dr Raab: Utilizing Early Bispecific Combos in Myeloma - Targeted Oncology
    November 17, 2025
  • New T Cell–Suppressive Pathway Highlights TSP-1–CD47 as Immunotherapy Booster - Genetic Engineering and Biotechnology News
    November 17, 2025
  • Thoracic Radiotherapy Boosts Metastatic Esophageal Cancer Outcomes - BIOENGINEER.ORG
    November 17, 2025

Immunotherapy News from China

  • UPDATE 2-U.S. FDA approves Merck immunotherapy/chemo combo …
  • …Announces Off-the-Shelf CAR T-cell Cancer Immunotherapy to…
  • UPDATE 2-U.S. FDA approves Merck immunotherapy/chemo combo …
  • …in Combination With Anti-PD-L1 Cancer Immunotherapy and …
  • …Dosed in First-in-Human Clinical Study of Immunotherapy …
  • JITC tumor and cancer immunotherapy papers collection
    JITC tumor and cancer immunotherapy papers collection
  • Welcome to the submission|Journal for ImmunoTherapy of Cancer
  • Immunotherapy shows promise for advanced lymphoma: study
  • …from the Monotherapy Arm at the Phacilitate Immunotherapy …
  • Allergy Immunotherapy Market to exceed US$ 3.33 Bn by 2025 …
  • Load more [+]

Copyright 2018 ImmunoTherapyToday.com